[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97.1K followers Created: 2025-07-17 09:09:30 UTC 🔸However, most of these drugs are expensive imports from the US, with monthly costs often exceeding ₹20,000 (e.g., Wegovy and Ozempic), making them unaffordable for many. This has created a strong push for domestic manufacturing, especially with patent expiries and government support likely through PLI schemes. As a result, the Indian GLP-1 market is expected to grow rapidly at a XXXX% CAGR through 2030. XXXXX engagements  **Related Topics** [pli](/topic/pli) [ozempic](/topic/ozempic) [wegovy](/topic/wegovy) [drugs](/topic/drugs) [Post Link](https://x.com/raghavwadhwa/status/1945772841728958644)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Raghav Wadhwa @raghavwadhwa on x 97.1K followers
Created: 2025-07-17 09:09:30 UTC
🔸However, most of these drugs are expensive imports from the US, with monthly costs often exceeding ₹20,000 (e.g., Wegovy and Ozempic), making them unaffordable for many. This has created a strong push for domestic manufacturing, especially with patent expiries and government support likely through PLI schemes. As a result, the Indian GLP-1 market is expected to grow rapidly at a XXXX% CAGR through 2030.
XXXXX engagements
